Switzerland-based neurotechnology company MindMaze which announced a new thought-powered system named MindLeap, for controlling virtual reality (VR) and augmented reality (AR) titles in early 2015 has revealed the results of a new funding round. Announced today the company has raised commitments of $100 million USD in a new round led by the Hinduja Group.
The funding will allow MindMaze to further build on the company’s track record for developing top-end medical-grade neural VR platforms. Its platform is designed around creating intuitive human machine interfaces combining VR, computer vision, neuroscience, AI and haptics. The technology is already used in healthcare to help a range of patients, including stroke victims in rehab and military veterans suffering from “phantom pain.”